Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
Home
Rechtssache C-224/20: Vorabentscheidungsersuchen des Sø- og Handelsret (Dänemark), eingereicht am 29. Mai 2020 — Merck Sharp & Dohme BV, Merck Sharp & Dohme Corp., MSD DANMARK ApS, MSD Sharp & Dohme GmbH, Novartis AG, FERRING LÆGEMIDLER A/S und H. Lundbeck A/S/Abacus Medicine A/S, Paranova Danmark A/S und 2CARE4 ApS
Rechtssache C-224/20: Vorabentscheidungsersuchen des Sø- og Handelsret (Dänemark), eingereicht am 29. Mai 2020 — Merck Sharp & Dohme BV, Merck Sharp & Dohme Corp., MSD DANMARK ApS, MSD Sharp & Dohme GmbH, Novartis AG, FERRING LÆGEMIDLER A/S und H. Lundbeck A/S/Abacus Medicine A/S, Paranova Danmark A/S und 2CARE4 ApS
Publication metadata
- Published:
- Corporate author(s): Court of Justice (Court of Justice of the European Union)
- Subject: EU trade mark , labelling , market approval , medicinal product , packaging , registered trademark , trademark law
- CELEX : 62020CN0224
- OJ : JOC_2020_279_R_0043
- IMMC : DDP-C-0224-2020
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages